RFA-NR-22-003: Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.
National Institutes of Health offered grants of up to $275,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on April 7, 2022.
From the official notice on Grants.gov, last changed January 26, 2022. Checked November 7, 2026.
- Award ceiling$275,000
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeR21
- Clinical trialsOptional
- Funded byNINR
- Median yearly award$224,436
- Typical project length2.5 years
- R21, Exploratory/Developmental Research Grant. Early, exploratory ideas that may not have preliminary data yet, usually for up to two years. Other open R21 notices.
Projects funded under RFA-NR-22-003 were run by National Institute of Nursing Research (NINR, 4 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-NR-22-003 in the NIH Guide.
Key dates
| Posted | January 26, 2022 |
|---|---|
| Deadline | April 7, 2022 |
| Archived by Grants.gov | May 13, 2022 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Projects NIH funded under this notice had a median yearly award of $224,436; it allows up to $275,000 per award.
- Most of the money in the 2 programs behind this notice (73% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
Persistent disparities in maternal health outcomes is a public health crisis that requires new insights and solutions. The purpose of this initiative is to support formative research and pilot studies to inform development of integrated models of care to prevent severe maternal morbidity and mortality among disproportionately impacted populations.
Funded under RFA-NR-22-003 so far
NIH funded 4 projects under RFA-NR-22-003 in fiscal 2022 to 2023, at 4 institutions. The median yearly award was $224,436.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Identifying Outcomes and Implementation Strategies to Optimize Prenatal Care Coordination | University of Wisconsin-Madison | 2023 | $187,715 |
| Comprehensive Postpartum Management for Women with Hypertensive Disorders of Pregnancy | Vanderbilt University Medical Center | 2023 | $222,282 |
| Brooklyn Digital Community Care Intervention to Address Unmet Social Needs and Optimize Engagement in Maternal Health Care | SUNY Downstate Medical Center | 2023 | $158,352 |
| Exploring the Preliminary Efficacy of Centering Pregnancy with Care Navigation to Reduce Maternal Health Disparities among Marshallese Women | Univ of Arkansas for Med Scis | 2023 | $229,500 |
Who has won Child Health and Human Development Extramural Research grants before
From fiscal 2021 to 2025, Child Health and Human Development Extramural Research (93.865) awarded $6.0 billion across 6,026 grant awards, an average of $1.0 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Regents of the University of Michigan | Michigan | 167 | $178 million |
| The Johns Hopkins University | Maryland | 133 | $146 million |
| University of Washington | Washington | 114 | $131 million |
| Baylor College of Medicine | Texas | 116 | $124 million |
| The Leland Stanford Junior University | California | 104 | $116 million |
Who has won Nursing Research grants before
From fiscal 2021 to 2025, Nursing Research (93.361) awarded $725 million across 786 grant awards, an average of $922,835 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Trustees of the University of Pennsylvania | Pennsylvania | 37 | $39.2 million |
| The Johns Hopkins University | Maryland | 43 | $31.3 million |
| The Trustees of Columbia University in the City of New York | New York | 28 | $29.7 million |
| University of Washington | Washington | 30 | $27.5 million |
| Emory University | Georgia | 31 | $27.0 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-NR-22-003 still open?
No. It closed on April 7, 2022.
Who can apply for Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional)?
Closed April 7, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $275,000 each.
Who has been funded under RFA-NR-22-003?
NIH RePORTER lists 4 projects funded under RFA-NR-22-003 in fiscal 2022 to 2023, at 4 institutions. The most were at University of Wisconsin-Madison, Vanderbilt University Medical Center, SUNY Downstate Medical Center.
Who has won Nursing Research grants before?
The largest recipients over five fiscal years were The Trustees of the University of Pennsylvania, The Johns Hopkins University, The Trustees of Columbia University in the City of New York. The program made 786 awards worth $725 million in that time.
Similar open grants
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
- Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)